Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Med Chem ; 64(13): 9259-9270, 2021 07 08.
Article in English | MEDLINE | ID: mdl-34160229

ABSTRACT

Tricyclic chemical structures are the core of many important drugs targeting all neurotransmitter pathways. These medicines enable effective therapies to treat from peptic ulcer disease to psychiatric disorders. However, when administered systemically, they cause serious adverse effects that limit their use. To obtain localized and on-demand pharmacological action using light, we have designed photoisomerizable ligands based on azobenzene that mimic the tricyclic chemical structure and display reversibly controlled activity. Pseudo-analogues of the tricyclic antagonist pirenzepine demonstrate that this is an effective strategy in muscarinic acetylcholine receptors, showing stronger inhibition upon illumination both in vitro and in cardiac atria ex vivo. Despite the applied chemical modifications to make pirenzepine derivatives sensitive to light stimuli, the most potent candidate of the set, cryptozepine-2, maintained a moderate but promising M1 vs M2 subtype selectivity. These photoswitchable "crypto-azologs" of tricyclic drugs might open a general way to spatiotemporally target their therapeutic action while reducing their systemic toxicity and adverse effects.


Subject(s)
Drug Design , Muscarinic Antagonists/pharmacology , Pirenzepine/pharmacology , Receptors, Muscarinic/metabolism , Dose-Response Relationship, Drug , Humans , Molecular Structure , Muscarinic Antagonists/chemical synthesis , Muscarinic Antagonists/chemistry , Pirenzepine/chemical synthesis , Pirenzepine/chemistry , Structure-Activity Relationship
2.
Chembiochem ; 22(10): 1800-1810, 2021 05 14.
Article in English | MEDLINE | ID: mdl-33554411

ABSTRACT

The observables associated with protein intrinsic fluorescence - spectra, time decays, anisotropies - offer opportunities to monitor in real time and non-invasively a protein's functional form and its interchange with other forms with different functions. We employed these observables to sketch the fluorometric profiles of two functional forms of human thymidylate synthase (hTS), a homodimeric enzyme crucial for cell proliferation and thus targeted by anticancer drugs. The protein takes an active and an inactive form. Stabilization of the latter by peptides that, unlike classical hTS inhibitors, bind it at the monomer/monomer interface offers an alternative inhibition mechanism that promises to avoid the onset of drug resistance in anticancer therapy. The fluorescence features depicted herein can be used as tools to identify and quantify each of the two protein forms in solution, thus making it possible to investigate the kinetic and thermodynamic aspects of the active/inactive conformational interchange. Two examples of fluorometrically monitored interconversion kinetics are provided.


Subject(s)
Fluorescence Polarization , Thymidylate Synthase/chemistry , Deoxyuracil Nucleotides/chemistry , Deoxyuracil Nucleotides/metabolism , Humans , Kinetics , Molecular Dynamics Simulation , Mutagenesis, Site-Directed , Protein Structure, Quaternary , Thymidylate Synthase/genetics , Thymidylate Synthase/metabolism
3.
J Med Chem ; 61(16): 7374-7380, 2018 08 23.
Article in English | MEDLINE | ID: mdl-30035541

ABSTRACT

LR and [d-Gln4]LR peptides bind the monomer-monomer interface of human thymidylate synthase and inhibit cancer cell growth. Here, proline-mutated LR peptides were synthesized. Molecular dynamics calculations and circular dichroism spectra have provided a consistent picture of the conformational propensities of the [Pro n]-peptides. [Pro3]LR and [Pro4]LR show improved cell growth inhibition and similar intracellular protein modulation compared with LR. These represent a step forward to the identification of more rigid and metabolically stable peptides.


Subject(s)
Antineoplastic Agents/pharmacology , Enzyme Inhibitors/pharmacology , Ovarian Neoplasms/drug therapy , Peptides/pharmacology , Thymidylate Synthase/antagonists & inhibitors , Antineoplastic Agents/chemistry , Cell Line, Tumor , Circular Dichroism , Enzyme Inhibitors/chemistry , Female , Humans , Molecular Dynamics Simulation , Mutation , Ovarian Neoplasms/pathology , Peptides/chemistry , Peptides/genetics , Proline/genetics , Protein Conformation , Thymidylate Synthase/genetics , Thymidylate Synthase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...